Prelude Therapeutics Inc (PRLD) KPIs and segments
PRLDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026Score 8/3066% above fair value
$3.52−0.26 (-6.88%)
Close on Nov 12, 2026Market cap $280.91MP/E –Yield –
KPIs & segments
Operating metrics and segments that drive Prelude Therapeutics's business
Coming soon
This tab will track the numbers specific to Prelude Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.
See a number that looks wrong?